Loading clinical trials...
Loading clinical trials...
The 'Lombard Effect' in Patients Affected by Adductor Laryngeal Dystonia: a Pilot Study
Adductory spasmodic dysphonia (AdSD) is a rare condition characterised by irregular and uncontrolled voice interruptions, most commonly affecting women around the age of 45. The diagnosis is clinical and usually requires evaluation by several specialists. The exact cause is not known, but a disturbance of the motor system is hypothesised, probably related to various causes such as loss of cortical inhibition or problems with sensory input. Neuroimaging studies have shown hyperactivity in various brain regions during speech production in patients with AdSD, but it is still unclear whether this hyperactivity is due to a malfunction of auditory and somatosensory feedback or an impairment of motor programming. Recent research indicates that patients with AdSD show excessive muscle activation during phonation, probably due to abnormal processing of auditory feedback. This suggests that intervention in the auditory system may offer new treatment opportunities. The proposed study aims to describe the acoustic, auditory-perceptual and subjective voice and speech changes in AdSD subjects during the Quick-Lombard Test (LT), a test that assesses vocal response under noisy conditions.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy
Start Date
May 1, 2024
Primary Completion Date
April 30, 2025
Completion Date
May 1, 2025
Last Updated
May 7, 2024
18
ESTIMATED participants
Lombard test
OTHER
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT05158166
NCT05158179
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions